A Rocky First Quarter For Big Pharma Stocks

 
• By Joseph Haas
  
Values decline of oil
Twelve of 13 big pharmas reviewed have suffered valuation declines over the first quarter
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip